| Particulars |
|
|
|
| Company Name
| Gland Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
16.48 |
B.V. (₹) |
610.00 |
| Sales(₹ Cr.) |
4,116.15 |
NP (₹ Cr.) |
1,088.78 |
| NP Var% |
4.00 |
Div% |
1,800.00 |
| CPS(₹) |
76.40 |
EPS (₹) |
66.10 |
| Traded Value(₹ Lakhs) |
2,894.76 |
52 Week High |
2,130.00 |
| 52 Week Low |
1,428.00 |
Price BSE |
1,895.00 |
| Price NSE |
1,898.00 |
Market Capital (₹ Cr.) |
31,223.81 |
| P/C Ratio |
24.80 |
P/E Ratio |
28.70 |
| Price Vs.BV |
3.11 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
1,177.51 |
| NP(₹ Cr.) |
325.69 |
NP Var % |
10.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
4,347.71 |
| OPM |
34.13 |
NP |
1,102.85 |
| NP Var% |
5.87 |
EPS |
72.04 |
| PE |
26.31 |
|
|